Cargando…
Nucleic acid polymer REP 2139 and nucleos(T)ide analogues act synergistically against chronic hepadnaviral infection in vivo in Pekin ducks
Nucleic acid polymer (NAP) REP 2139 treatment was shown to block the release of viral surface antigen in duck HBV (DHBV)‐infected ducks and in patients with chronic HBV or HBV/hepatitis D virus infection. In this preclinical study, a combination therapy consisting of REP 2139 with tenofovir disoprox...
Autores principales: | Quinet, Jonathan, Jamard, Catherine, Burtin, Madeleine, Lemasson, Matthieu, Guerret, Sylviane, Sureau, Camille, Vaillant, Andrew, Cova, Lucyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001552/ https://www.ncbi.nlm.nih.gov/pubmed/29251788 http://dx.doi.org/10.1002/hep.29737 |
Ejemplares similares
-
Role of Cell-Penetrating Peptides in Intracellular Delivery of Peptide Nucleic Acids Targeting Hepadnaviral Replication
por: Ndeboko, Bénédicte, et al.
Publicado: (2017) -
Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen
por: Angelo, Léna, et al.
Publicado: (2023) -
Developments in Cell-Penetrating Peptides as Antiviral Agents and as Vehicles for Delivery of Peptide Nucleic Acid Targeting Hepadnaviral Replication Pathway
por: Ndeboko, Bénédicte, et al.
Publicado: (2018) -
Nucleic Acid Polymers with Accelerated Plasma and Tissue Clearance for Chronic Hepatitis B Therapy
por: Roehl, Ingo, et al.
Publicado: (2017) -
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients
por: Jung, Sang Kyung, et al.
Publicado: (2015)